Cationic liposomes loaded with proapoptotic peptide D-(KLAKLAK)(2) and Bcl-2 antisense oligodeoxynucleotide G3139 for enhanced anticancer therapy.
Cationic liposomes loaded with proapoptotic peptide D-(KLAKLAK)(2) and Bcl-2 antisense oligodeoxynucleotide G3139 for enhanced anticancer therapy.
复制标题
DOI:
10.1021/mp900006h
复制
发表时间:
2009-05
影响因子:
4.9
通讯作者:
Torchilin VP
中科院分区:
文献类型:
--
作者:
Ko YT;Falcao C;Torchilin VP
The treatment of cancer using macromolecular therapeutics such as oligonucleotides or peptides requires efficient delivery systems capable of intracellular penetration and may also benefit from use of a combination of therapeutics with different mechanisms of action. With this possibility in mind, we constructed cationic liposome loaded with the proapoptotic peptide, D-(KLAKLAK)2 and the bcl-2 antisense oligodeoxynucleotide, G3139, and determined whether the combination of the proapoptotic macromolecules in a single cationic liposome can enhance antitumor efficacy. Advantage was taken of alternating charge interaction to entrap macromolecules of opposite charge. The polycationic pepetide D-(KLAKLAK)2 was first condensed with the polyanionic oligodeoxynucleotide G3139 to obtain overall negatively charged peptide/oligodeoxynucleotide complexes. The complexes were then entrapped into DOTAP/DOPE cationic liposomes (CL). This sequential charge interaction ensured efficient entrapment of D-(KLAKLAK)2 and G3139 with a high loading efficiency (50 %) and capacity (7.5 wt%). In vitro treatment of mouse melanoma B16(F10) with CL loaded with D-(KLAKLAK)2/G3139 led to significantly enhanced antitumor efficacy, mediated by stimulated induction of apoptotic (Caspase 3/7) activity, when compared to CL loaded with G3139 alone. Intratumoral injection of CL loaded with D-(KLAKLAK)2/G3139 in B16(F10) mice xenograft also led to suppressed tumor growth associated with enhanced apoptotic activity. Thus, the combination of proapoptotic peptide D-(KLAKLAK)2 and antisense oligonucleotide G3139 in a cationic liposome led to enhanced apoptotic/antitumor efficacy and may provide a promising tool for cancer treatment.
登录
查看更多内容
影响因子:
11.5
作者:
Dai, GW;Chan, KK;Marcucci, G
通讯作者:
Marcucci, G
影响因子:
10.8
作者:
Zhao, Hong;Peng, Ping;Stein, C. A.
通讯作者:
Stein, C. A.
影响因子:
168.9
作者:
Jansen, B;Wacheck, V;Pehamberger, H
通讯作者:
Pehamberger, H
影响因子:
82.9
作者:
Ellerby, HM;Arap, W;Pasqualini, R
通讯作者:
Pasqualini, R
影响因子:
11.2
作者:
Marks, AJ;Cooper, MS;Wickremasinghe, RG
通讯作者:
Wickremasinghe, RG